These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 39154046)
41. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. Ding Q; Li R; Wang Q; Yu L; Zi F Front Oncol; 2023; 13():1049147. PubMed ID: 38053661 [TBL] [Abstract][Full Text] [Related]
42. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
43. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker. Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423 [TBL] [Abstract][Full Text] [Related]
44. Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment. Wu Z; Pan T; Li W; Zhang YH; Guo SH; Liu Y; Zhang L; Wang ZY Clin Transl Oncol; 2024 Oct; 26(10):2701-2717. PubMed ID: 38642258 [TBL] [Abstract][Full Text] [Related]
45. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers. Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977 [TBL] [Abstract][Full Text] [Related]
46. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer. Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444 [TBL] [Abstract][Full Text] [Related]
47. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis. Zhao C; Xiong K; Ji Z; Liu F; Li X Oxid Med Cell Longev; 2022; 2022():8297011. PubMed ID: 35313641 [TBL] [Abstract][Full Text] [Related]
48. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe? Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q Gene; 2022 Oct; 840():146765. PubMed ID: 35905855 [TBL] [Abstract][Full Text] [Related]
49. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker. Yang W; Liu Z; Liu T Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265 [TBL] [Abstract][Full Text] [Related]
50. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis. Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y Front Immunol; 2022; 13():951247. PubMed ID: 35935945 [TBL] [Abstract][Full Text] [Related]
51. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers. Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L Front Oncol; 2022; 12():916907. PubMed ID: 35785154 [TBL] [Abstract][Full Text] [Related]
52. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Huang L; Irshad S; Sultana U; Ali S; Jamil A; Zubair A; Sultan R; Abdel-Maksoud MA; Mubarak A; Almunqedhi BM; Almanaa TN; Malik A; Alamri A; Kodous AS; Mares M; Zaky MY; Saba Sajjad S; Hameed Y Am J Transl Res; 2024; 16(3):873-888. PubMed ID: 38586106 [TBL] [Abstract][Full Text] [Related]
53. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis. Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545 [TBL] [Abstract][Full Text] [Related]
54. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191 [TBL] [Abstract][Full Text] [Related]
55. MARCO is a potential prognostic and immunotherapy biomarker. Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567 [TBL] [Abstract][Full Text] [Related]
56. Can CpG methylation serve as surrogate markers for immune infiltration in cancer? Bacolod MD; Barany F; Fisher PB Adv Cancer Res; 2019; 143():351-384. PubMed ID: 31202362 [TBL] [Abstract][Full Text] [Related]
57. Role of CD47 in tumor immunity: a potential target for combination therapy. Huang J; Liu F; Li C; Liang X; Li C; Liu Y; Yi Z; Zhang L; Fu S; Zeng Y Sci Rep; 2022 Jun; 12(1):9803. PubMed ID: 35697717 [TBL] [Abstract][Full Text] [Related]
58. Pan-Cancer Analysis Revealed Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J J Oncol; 2022; 2022():3477148. PubMed ID: 35069733 [TBL] [Abstract][Full Text] [Related]
59. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification. Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026 [TBL] [Abstract][Full Text] [Related]
60. The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer. Wolde T; Bhardwaj V; Reyad-Ul-Ferdous M; Qin P; Pandey V Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]